Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Asset disposition
Revolution Medicines, Inc. (RVMD) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Quarterly results
Docs: "Revolution Medicines Reports Second Quarter 2023 Financial Results and Update on Corporate Progress Company to provide clinical updates for RMC-6236 at Triple Meeting and ESMO Congress 2023 and initial clinical findings for RMC-6291 at Triple Meeting Planning underway for one or more single agent pivotal trials with RMC-6236 and the first combination study of RMC-6236 and RMC-6291 Announced acquisition of EQRx, Inc. expected to add more than $1 billion in additional capital to balance sheet Webcast today at 4:30 p.m. Eastern Time REDWOOD CITY, Calif., August 8, 2023"
05/08/2023 8-K Quarterly results
Docs: "Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress First Wave of Investigational RAS Inhibitors – RMC-6236 , RMC-6291 and RMC-9805 – progressing on plan Appointment of chief medical officer and key leaders across late-stage development and commercial planning $909.8 million in cash, cash equivalents and investments at the end of first quarter 2023 Conference call and webcast today at 4:30 p.m. Eastern Time REDWOOD CITY, Calif., May 8, 2023"
11/07/2022 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Revolution Medicines Reports Third Quarter 2022 Financial Results and Update on Corporate Progress"
08/09/2022 8-K Quarterly results
Docs: "Revolution Medicines Reports Second Quarter 2022 Financial Results and Update on Corporate Progress"
05/09/2022 8-K Quarterly results
02/28/2022 8-K Quarterly results
11/10/2021 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress"
08/11/2021 8-K Quarterly results
Docs: "Revolution Medicines Reports Second Quarter Financial Results and Update on Corporate Progress"
05/10/2021 8-K Quarterly results
03/02/2021 8-K Quarterly results
11/12/2020 8-K Quarterly results
Docs: "Revolution Medicines Reports Third Quarter 2020 Financial Results and Update on Corporate Progress"
08/10/2020 8-K Quarterly results
05/14/2020 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy